124443-69-2 Usage
General Description
1-Piperidinecarboxylic acid, 4-[[1-[(4-fluorophenyl)methyl]-1H-benzimidazol-2-yl]carbonyl]-, 1,1-dimethylethyl ester, also known as Rabeprazole sodium, is a medication used to treat conditions such as gastroesophageal reflux disease (GERD) and stomach ulcers. It works by decreasing the amount of acid produced in the stomach. Rabeprazole sodium is a proton pump inhibitor (PPI) and is commonly prescribed in both oral and intravenous forms. The chemical structure of Rabeprazole sodium includes a piperidine ring and a benzimidazole ring, which are important for its acid-inhibiting properties. It is typically well-tolerated, but may have some side effects such as headache, diarrhea, and abdominal pain.
Check Digit Verification of cas no
The CAS Registry Mumber 124443-69-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,4,4,4 and 3 respectively; the second part has 2 digits, 6 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 124443-69:
(8*1)+(7*2)+(6*4)+(5*4)+(4*4)+(3*3)+(2*6)+(1*9)=112
112 % 10 = 2
So 124443-69-2 is a valid CAS Registry Number.
124443-69-2Relevant articles and documents
SUBSTITUTED N-METHYL-N-(4-(PIPERIDIN-1-YL)-2-(ARYL)BUTYL)BENZAMIDES USEFUL FOR THE TREATMENT OF ALLERGIC DISEASES
-
, (2008/06/13)
The present invention relates to novel substituted N-methyl-N-(4-(piperidin-1-yl)-2-(aryl)butyl)benzamide derivatives of the formula STR1 stereoisomers thereof, and pharmaceutically acceptable salts thereof which are useful as histamine receptor antagonists and tachykinin receptor antagonists. Such antagonists are useful in the treatment of allergic rhinitis, including seasonal rhinitis and sinusitis; inflammatory bowel diseases, including Crohn's disease and ulcerative colitis; asthma; bronchitis; and emesis.
A Highly Convergent Synthesis of Benzimidazolylpiperidines
Carr, Albert A.,Hay, David A.,Kane, John M.,Staeger, Michael A.
, p. 1399 - 1401 (2007/10/02)
-
